CRIS Current Research Information System

PICCALUGA, PIER PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.836
EU - Europa 13.214
AS - Asia 11.839
SA - Sud America 785
AF - Africa 749
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 8
Totale 41.454
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.632
IT - Italia 4.631
CN - Cina 3.408
SG - Singapore 3.271
GB - Regno Unito 2.694
VN - Vietnam 2.603
DE - Germania 1.275
SE - Svezia 1.223
FR - Francia 737
HK - Hong Kong 718
IN - India 661
UA - Ucraina 573
BR - Brasile 569
RU - Federazione Russa 569
IE - Irlanda 372
ZA - Sudafrica 280
NL - Olanda 249
JP - Giappone 223
EE - Estonia 173
TG - Togo 170
KR - Corea 165
CH - Svizzera 158
BD - Bangladesh 144
CI - Costa d'Avorio 143
FI - Finlandia 142
CA - Canada 129
AR - Argentina 85
IR - Iran 82
JO - Giordania 77
ID - Indonesia 70
PH - Filippine 64
TR - Turchia 64
BG - Bulgaria 63
BE - Belgio 59
TH - Thailandia 45
IQ - Iraq 44
SC - Seychelles 43
GR - Grecia 41
PL - Polonia 40
EC - Ecuador 38
MX - Messico 38
PK - Pakistan 37
ES - Italia 33
NG - Nigeria 28
TW - Taiwan 28
CL - Cile 27
HR - Croazia 27
LU - Lussemburgo 25
AT - Austria 24
RO - Romania 24
LB - Libano 22
SA - Arabia Saudita 22
UZ - Uzbekistan 22
CO - Colombia 20
PY - Paraguay 18
LT - Lituania 15
AU - Australia 13
EG - Egitto 13
KE - Kenya 12
MY - Malesia 12
MA - Marocco 11
TN - Tunisia 11
AE - Emirati Arabi Uniti 10
VE - Venezuela 10
ET - Etiopia 9
PT - Portogallo 9
UY - Uruguay 9
DZ - Algeria 8
HU - Ungheria 8
NZ - Nuova Zelanda 8
SK - Slovacchia (Repubblica Slovacca) 8
AL - Albania 7
CZ - Repubblica Ceca 7
IL - Israele 7
KZ - Kazakistan 7
NP - Nepal 7
PE - Perù 7
JM - Giamaica 6
DO - Repubblica Dominicana 5
GH - Ghana 5
RS - Serbia 5
CR - Costa Rica 4
HN - Honduras 4
KG - Kirghizistan 4
MD - Moldavia 4
OM - Oman 4
SI - Slovenia 4
TT - Trinidad e Tobago 4
XK - ???statistics.table.value.countryCode.XK??? 4
AO - Angola 3
AZ - Azerbaigian 3
BA - Bosnia-Erzegovina 3
IS - Islanda 3
PA - Panama 3
PR - Porto Rico 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
BF - Burkina Faso 2
BO - Bolivia 2
BS - Bahamas 2
Totale 41.411
Salva come PNG Salva come JPEG
Città #
Southend 2.359
Singapore 2.207
Fairfield 1.583
Ashburn 1.499
Chandler 930
Houston 797
Woodbridge 759
San Jose 727
Seattle 717
Wilmington 703
Hong Kong 678
Cambridge 576
Princeton 575
Ann Arbor 519
Ho Chi Minh City 519
Santa Clara 472
Hanoi 453
Dong Ket 450
Beijing 438
Milan 425
Dublin 363
Hefei 340
Rome 324
Boardman 315
Bologna 311
Jacksonville 299
Lauterbourg 279
Nanjing 271
Padova 254
Westminster 240
Los Angeles 204
New York 193
Tokyo 193
Lomé 169
Abidjan 143
Jinan 137
Shenyang 135
Berlin 131
Naples 128
Saint Petersburg 127
Seoul 124
Turin 122
Buffalo 120
Helsinki 119
Bern 118
Bremen 110
Hebei 107
Council Bluffs 102
Dallas 95
Changsha 94
Nanchang 88
São Paulo 84
Florence 83
Mülheim 82
Frankfurt am Main 80
San Diego 79
Redondo Beach 78
Amman 76
Guangzhou 76
Da Nang 72
Tianjin 71
Parma 69
Haiphong 63
Shanghai 61
Sofia 61
Medford 60
Hangzhou 58
Jiaxing 56
Brussels 54
Verona 51
Phoenix 50
Hyderabad 49
Zhengzhou 49
London 45
Toronto 45
Haikou 42
Falls Church 41
Bengaluru 40
Redwood City 40
Montreal 39
Orem 39
Munich 38
Palermo 38
Taizhou 38
San Francisco 36
Chicago 35
Dearborn 35
Ningbo 35
Taiyuan 35
Yubileyny 35
The Dalles 34
Johannesburg 33
Mahé 33
Jakarta 32
San Venanzo 32
Cagliari 31
Norwalk 29
Olalla 29
Bari 28
Warsaw 28
Totale 25.568
Salva come PNG Salva come JPEG
Nome #
Linfomi non Hodgkin di derivazione dai linfociti T-periferici. 1.920
Instillazione diretta intranasale di amfotericina B liposomiale nella terapia delle micosi nasali. 860
Linfomi non Hodgkin di derivazione dai linfociti T-periferici. 641
Leucemia Acuta Linfoide. 519
Efficacy and Clinical Outcome of Philadelphia (Ph) Positive Acute Lymphoblastic Leukemia (ALL) Patients Treated with Second Generation Tyrosine Kinase Inhibitors (TKIs): The Bologna Experience 355
ANALYSIS OF THE CODING GENOME OF SPLENIC MARGINAL ZONE LYMPHOMA REVEALS MUTATIONAL ACTIVATION OF NOTCH2 AND OTHER PATHWAYS REGULATING MARGINAL ZONE DIFFERENTIATION 327
Ficoll-hypaque separation vs whole blood lysis: Comparison of efficiency and impact on minimal residual disease analysis 286
Biology and treatment of follicular lymphoma. 282
IFI16 reduced expression is correlated with unfavorable outcome in chronic lymphocytic leukemia 268
The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort study 258
CDKN1B/p27 expression in peripheral T cell lymphoma not otherwise specified. 252
Pathogenetic and diagnostic significance of microRNA deregulation in peripheral T-cell lymphoma not otherwise specified 250
The evolution of clonality testing in the diagnosis and monitoring of hematological malignancies 243
Comparison of two real-time quantitative polymerase chain reaction strategies for minimal residual disease evaluation in lymphoproliferative disorders: correlation between immunoglobulin gene mutation load and real-time quantitative polymerase chain reaction performance 236
IFI16 expression is related to selected transcription factors during B-cell differentiation 231
Large cell non Hodgkin’s lymphoma: what is new in the WHO classification? 228
Distinct Viral and Mutational Spectrum of Endemic Burkitt Lymphoma 223
Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients. 222
Alemtuzumab in the treatment of relapsed acute lymphoid leukaemia. 221
First experience with gemtuzumab ozogamicin plus cytarabine as continuous infusion for elderly acute myeloid leukaemia patients. 218
A novel patient-derived tumorgraft model with TRAF1-ALK anaplastic large-cell lymphoma translocation 218
Advances in the treatment for haematological malignancies. 215
Burkitt lymphoma beyond MYC translocation: N-MYC and DNA methyltransferases dysregulation 214
Genetic profiling in acute myeloid leukemia: a path to predicting treatment outcome 213
Identification of a novel t(1;9)(q11;q34) in acute myelocytic leukemia 212
Identification of outcome predictors in diffuse large B-cell lymphoma. Immunohistochemical profiling of homogeneously treated de novo tumors with nodal presentation on tissue micro-arrays. 209
Advances and potential treatment for Philadelphia chromosome-positive adult acute lymphoid leukaemia. 209
No preferential sensitivity of t(8;21) acute myeloid leukemias to cytosine arabinoside in vitro: is intensity of therapy or high dose Ara-C crucial for response? 208
Gemtuzumab ozogamicin for relapsed and refractory acute myeloid leukemia and myeloid sarcomas 208
Expression of CD52 in peripheral T-cell lymphoma. 208
First-line treatment of chronic myeloid leukemia with nilotinib: critical evaluation. 207
Conditioning regimens in acute myeloid leukemia. 203
FIRMA MOLECOLARE E SUOI USI COME AGENTE DIAGNOSTICO 200
Systemic Epstein-Barr-virus-positive T cell lymphoproliferative childhood disease in a 22-year-old Caucasian man: A case report and review of the literature 199
Linfomi non Hodgkin di derivazione dai linfociti T-periferici primitivi della cute. 198
Epstein-Barr Virus-Induced Metabolic Rearrangements in Human B-Cell Lymphomas 197
Complete and long-lasting cytologic and molecular remission of FIP1L1-PDGFRA-positive acute eosinophil myeloid leukaemia, treated with low-dose imatinib monotherapy 196
Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-kB pathway inhibition 196
The Bcr-Abl kinase promotes aberrant expression of spliced oncogenic Ikaros isoforms in Philadelphia (Ph) positive acute lymphoblastic leukemia (ALL) patients treated with tyrosine kinase inhibitors 195
MINIMAL RESIDUAL DISEASE (MRD) EVALUATION IN LYMPHOMAS WITHIN THE FIL (FONDAZIONE ITALIANA LINFOMI) MRD NETWORK: INTER-LABORATORY REPRODUCIBILITY ON BORDERLINE SAMPLES 195
Erythrophagocytosis by neoplastic cells in a patient with myelodysplastic syndrome 194
Increased angiogenesis seems to correlate with inferior overall survival in myeloid sarcoma patients 194
MicroRNAs sequencing unveils distinct molecular subgroups of plasmablastic lymphoma 193
Association of 3q21q26 syndrome with different RPN1/EVI1 fusion transcripts 192
Low-dose lenalidomide plus cytarabine in very elderly, unfit acute myeloid leukemia patients: Final result of a phase II study 191
Unveiling another missing piece in EBV-driven lymphomagenesis: EBV-encoded microRNAs expression in EBER-negative Burkitt lymphoma cases 191
Molecular Profiling Improves Classification and Prognostication of Nodal Peripheral T-Cell Lymphomas: Results of a Phase III Diagnostic Accuracy Study 191
Pathobiologic Roles of Epstein-Barr Virus-Encoded MicroRNAs in Human Lymphomas 191
Platelet-derived growth factor alpha mediates the proliferation of peripheral T-cell lymphoma cells via an autocrine regulatory pathway. 190
Virus-encoded microRNA contributes to the molecular profile of EBV-positive Burkitt lymphomas 189
Single-Step IGHV Next-Generation Sequencing Detects Clonality and Somatic Hypermutation in Lymphoid Malignancies: A Phase III Diagnostic Accuracy Study 188
Bone marrow stroma CD40 expression correlates with inflammatory mast cell infiltration and disease progression in splenic marginal zone lymphoma 188
Duplex real-time polymerase chain reaction assay for the detection of human KIPyV and WUPyV in nasopharyngeal aspirate pediatric samples 187
A novel immunohistochemical classifier to distinguish Hodgkin lymphoma from ALK anaplastic large cell lymphoma. 186
Molecular signature of Epstein Barr virus-positive Burkitt lymphoma and post-transplant lymphoproliferative disorder suggest different roles for Epstein Barr virus 186
A targeted mutational landscape of angioimmunoblastic T-cell lymphoma 186
Defective stromal remodeling and neutrophil extracellular traps in lymphoid tissues favor the transition from autoimmunity to lymphoma 185
Frequent Elevation of Akt Kinase Phosphorylation in Blood Marrow and Peripheral Blood Mononuclear Cells from High Risk myelodysplastic Syndrome Patients 184
SNPs array karyotyping reveals a novel recurrent 20p13 amplification in primary myelofibrosis. 183
Beyond NPM-anaplastic lymphoma kinase driven lymphomagenesis 183
CDKN1B/P27 expression in peripheral T-cell lymphoma not otherwise specified 182
BCL10 down-regulation in peripheral T-cell lymphomas. 179
Pathobiology of hodgkin lymphoma. 179
Prompt resolution of nasal aspergillosis with intranasal instillation of liposomal amphotericin-B (amBisome) and granulocyte transfusions 177
Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma 176
SNPs Array Karyotyping in Non-Hodgkin Lymphoma 176
An observational study of once weekly intravenous ganciclovir as CMV prophylaxis in heavily pre-treated chronic lymphocytic leukemia patients receiving subcutaneous alemtuzumab. 173
Characterization of a new monoclonal antibody against PAX5/BASP in 1525 paraffin-embedded human and animal tissue samples. 173
Single-agent panobinostat for relapsed/refractory diffuse large B-cell lymphoma: clinical outcome and correlation with genomic data. A phase 2 study of the Fondazione Italiana Linfomi 173
Cytoplasmic mutated nucleophosmin (NPM1) in blast crisis of chronic myeloid leukaemia. 172
Molecular profiling of aggressive lymphomas 172
Primary cardiac non-Hodgkin lymphoma presenting with atrial flutter and pericardial effusion. 171
Dose increase of imatinib mesylate may overcome acquired resistance in bcr/abl-positive acute lymphoid leukaemia 171
Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score. 170
Pathobiology of anaplastic large cell lymphoma. 170
Chronic inflammation, including Autoimmunity, and Lymphomagenesis. 170
Clonality analysis of immunoglobulin gene rearrangement by next-generation sequencing in endemic burkitt lymphoma suggests antigen drive activation of bcr as opposed to sporadic burkitt lymphoma 170
Another look at follicular lymphoma: immunophenotypic and molecular analyses identify distinct follicular lymphoma subgroups 169
Blastic plasmacytoid dendritic cell neoplasm: is it time to redefine the standard of care? 168
Anti-leukemic and anti-GVHD effects of campath-1H in acute lymphoblastic leukemia relapsed after stem-cell transplantation. 168
Linfomi a cellule T periferiche NAS: nuovo indice prognostico. 166
Evaluation of Modified PEG-Anilinoquinazoline Derivatives as Potential Agents for EGFR Imaging in Cancer by Small Animal PET. 166
Molecular genetics of peripheral T-cell lymphomas 165
The cell of origin of Burkitt lymphoma: germinal centre or not germinal centre? 165
Mesenchymal stromal cells (MSCs) induce ex vivo proliferation and erythroid commitment of cord blood haematopoietic stem cells (CB-CD34+ cells) 165
The Prognostic value of tumor and microenvironment markers in classifical Hodgkin lymphoma (CHL) patients. 164
Presence or the Emergence of a F317L BCR-ABL Mutation May Be Associated With Resistance to Dasatinib in Philadelphia Chromosome Positive Leukemia 164
Assessment Of Sars-Cov-2 Igg And Igm Antibody Detection With A Lateral Flow Immunoassay Test 163
Targeted molecular therapy in peripheral T-cell lymphomas 161
Vascular endothelial growth factor A (VEGFA) expression in mycosis fungoides 161
The presence of Epstein-Barr virus significantly impacts the transcriptional profile in immunodeficiency-associated Burkitt lymphoma 161
The development of more than one histologic type of lymphoma in the same patient is frequent and confers a worse prognosis 160
Pathobiology of ALK-negative anaplastic large cell lymphoma. 160
Preferential usage of specific immunoglobulin heavy chain variable region genes with unmutated profile and advanced stage at presentation are common features in patients with chronic lymphocytic leukemia from Senegal 160
Molecular Profiling of Kenyan Acute Myeloid Leukemia Patients 159
The alteration of lipid metabolism in Burkitt lymphoma identifies a novel marker: adipophilin. 158
Multicentre phase III trial on fludarabine, cytarabine (Ara-C), and idarubicin versus idarubicin, Ara-C and etoposide for induction treatment of younger, newly diagnosed acute myeloid leukaemia patients 158
Gene expression profile predicts response to the combination of tosedostat and low-dose cytarabine in elderly AML 157
Resolving the diagnostic dilemma of T-cell clonal expansion after hematopoietic stem cell transplantation in T-cell lymphoma patients by TCR-gamma next generation sequencing 156
Hsa-miR-15a and Hsa-miR-16-1 Expression Is Not Related to Proliferation Centers Abundance and Other Prognostic Factors in Chronic Lymphocytic Leukemia 155
Totale 22.595
Salva come PNG Salva come JPEG
Categoria #
all - tutte 109.458
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 109.458
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021988 0 0 0 0 0 0 0 0 0 0 0 988
2021/20224.470 353 178 292 365 443 293 95 280 225 373 909 664
2022/20235.150 641 704 254 655 313 385 164 266 866 141 456 305
2023/20242.205 124 248 121 172 151 299 172 179 91 187 199 262
2024/20255.472 325 876 480 416 834 294 580 204 105 262 169 927
2025/202611.723 761 921 1.105 1.047 1.388 684 1.028 350 2.530 1.044 461 404
Totale 42.127